Position in ADMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,848,828
+$911,963 QoQ
Shares Held
1,176,682
+18.6% QoQ
Ownership
0.525%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#36
of 323 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Derivatives in ADMA
reported options exposure · as of Jun 30, 2026CallValue
$523,125
CallShares
62,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BOOTHBAY FUND MANAGEMENT, LLC holds $665,103,201 across 158 Biotechnology names. ADMA ranks #15 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
465,787 | $87,232,589 | |
| 2 | ABVX |
Abivax S.A.
|
563,367 | $75,074,286 | |
| 3 | EXEL |
Exelixis, Inc.
|
804,095 | $43,750,808 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
534,163 | $31,050,895 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
692,825 | $26,812,327 | |
| 6 | CGEM |
Cullinan Therapeutics, Inc.
|
1,082,611 | $19,714,346 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
500,497 | $15,645,536 | |
| 8 | AVTX |
Avalo Therapeutics, Inc.
|
702,051 | $12,973,902 |
All Filings in ADMA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $523,125 | 62,500 | Call | Other | 2026-08-14 | |
| 2026-06-30 | $9,848,828 | 1,176,682 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $8,936,865 | 991,883 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $563,125 | 62,500 | Call | Other | 2026-05-15 | |
| 2025-12-31 | $14,379,540 | 788,352 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $11,334,496 | 773,158 | Shares | Other | 2025-11-14 | |
| 2024-06-30 | $5,515,216 | 493,311 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $5,192,926 | 786,807 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $4,925,471 | 1,089,706 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $3,741,858 | 1,045,212 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $3,741,058 | 1,013,837 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $4,086,208 | 1,234,504 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $4,079,373 | 1,051,385 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $19,734,401 | 8,121,153 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $20,513,592 | 10,360,400 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $19,047,113 | 10,408,259 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $11,680,242 | 8,283,860 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $3,537,505 | 3,130,536 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $363,950 | 227,469 | Shares | Other | 2021-08-17 | |
| 2021-03-31 | $357,427 | 203,084 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $279,893 | 143,535 | Shares | Other | 2021-02-12 | |
| 2020-09-30 | $215,295 | 90,082 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $259,305 | 88,500 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $434,139 | 150,743 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||